Cas:1245643-13-3 (R)-4-Benzyl-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid manufacturer & supplier

Chemical Name:(R)-4-Benzyl-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid

CAS.NO:1245643-13-3

Synonyms:(2R)-4-benzyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylic acid

Molecular Formula:C₁₇H₂₄N₂O₄

Molecular Weight:320.38300

HS Code:2933599090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:70.08000

Exact Mass:320.17400

LogP:2.06830

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (2R)-4-benzyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2R)-4-benzyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2R)-4-benzyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylic acid Use and application,(2R)-4-benzyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperazine-2-carboxylic acid technical grade,usp/ep/jp grade.

Related News: The move follows a Class I recall, the FDA’s most serious, launched by Innova in late April amid “significant concerns” about the test’s accuracy—and alongside an official warning letter delivered to the company this week. (R)-4-Benzyl-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid manufacturer In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. (R)-4-Benzyl-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid supplier Developing countries such as China and India have good foundations for undertaking global industrial transfers because of their comparative advantages. With the continuous improvement of China’s fine chemical technology level, the types of products and market shares in China’s undertaking industrial transfer have gradually increased. (R)-4-Benzyl-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid vendor We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. (R)-4-Benzyl-1-(tert-butoxycarbonyl)piperazine-2-carboxylic acid factory We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.